- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
ARCHIVE Published on: 2015-02-13
Based on conversations with patients, providers, and other stakeholders in California
Americans for Safe Access (ASA), the nation’s leading medical cannabis patients’ advocacy organization, strongly supports appropriate regulation and licensing of commercial medical cannabis activity in California. Our research[i] and experience with more than ten years of local regulation show that sensible regulations preserve local access to medicine for patients, while reducing crime and complaints in neighborhoods.
More than 1.4 million Californians have used medical cannabis, and 92% of those surveyed report getting significant relief from a serious medical condition – chronic pain, arthritis, migraines, cancer, and others.[ii] Medical cannabis is real medicine, and it works. ASA calls on lawmakers and regulators to treat it like medicine when writing regulations that affect legal patients.
ASA believes that workable regulations and state licensing are an important part of expanding and preserving safe, legal, and dignified access to medical cannabis in California. We call on lawmakers, patients, and other stakeholders to cooperate in creating legislation that works for everyone. These “Points of Unity” are designed to help facilitate that process. Your input is welcome.
Points of Unity:
- Qualified Patients and their designated Primary Caregivers should be allowed to cultivate medical cannabis for the Qualified Patient’s personal medical use without any additional requirements for registration, licensing, regulation, or taxation.
- Regulations for commercial medical cannabis activity should provide incentives for cities and counties to adopt regulations and licensing ordinances, instead of bans on patients’ cooperatives and collectives.
- Regulations for commercial medical cannabis activity should be reasonable and facilitate access for Qualified Patients.
- Regulations for commercial medical cannabis activity should include provisions to protect the health, safety, and privacy of Qualified Patients and Primary Caregivers.
- Regulations for commercial medical cannabis activity related to product safety should be based on objective recommendations and scientific principles, like those published by the American Herbal Products Association in 2014[iii] and the American Herbal Pharmacopeia in 2013[iv].
- Fees associated with licensing should be reasonable and tiered to accommodate all sizes of medical cannabis businesses and organizations.
- Because taxation results in higher costs for Qualified Patients, any additional tax on medical cannabis should be eliminated, reduced, or limited.
- Medical cannabis should be regulated like herbal medicine, not like a vice (i.e. alcohol or cigarettes).
- The needs of Qualified Patients differ from those of non-medical cannabis consumers. Regulations should reflect these differences.
- Qualified Patients and their designated Primary Caregivers should not give up any existing rights in order to establish commercial regulations or legalize cannabis for adult use.
- Qualified patients should be protected from discrimination, including discrimination in employment, housing parental rights, and equal access to health care.
ASA’s California Campaign for Safe Access:
ASA’s California email discussion list:
ASA’s Medical Cannabis Advocates Training Center:
[i] Medical Cannabis Dispensing Collectives and Cooperatives and Local Regulation, Americans for Safe Access (Updated 2010).
[ii] “Prevalence of medical marijuana use in California: 2012,” Drug and Alcohol Review (2014), DOI: 10.111/dar. 12207.
[iii] Recommendations for Regulators – Cannabis Operations, American Herbal Products Association, 2014.
[iv] Cannabis Inflorescence, American Herbal Pharmacopeia, 2013.